BridgeMD
New treatment option for Stroke
Official title Brain STimulation for Arm Recovery After Stroke 2
ClinicalTrials.gov ID: NCT06265766
What this study is testing
- What it's testing
- Rationale: Every year, about 40,000 people in the Netherlands have a stroke. After the initial admission to the hospital, about 15% of stroke survivors is admitted to a rehabilitation center because of remaining disabilities.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age, 18 years or older
- First-ever unilateral ischemic stroke or intracerebral hemorrhage in a cerebral hemisphere or the brainstem;
- Unilateral upper limb paresis with a motricity index between 9 and 99;
- Possibility to start cTBS treatment within 21 days after stroke onset;
- Signed informed consent.
You likely can't join if
- Upper limb paresis prior to stroke onset;
- Absolute contra-indication to TMS
- Magnetic sensitive objects implanted in the head or neck area (e.g. cochlear implants, implanted neurostimulator, pacemaker or defibrillator, metal...
- History of epilepsy;
- Other contra-indications that may potentially be harmful as determined by the treating rehabilitation physician;
- Severe impairments that can impede study participation as determined by the treating rehabilitation physician (i.e. extreme fatigue, severe...
See the full eligibility criteria
- Age, 18 years or older
- First-ever unilateral ischemic stroke or intracerebral hemorrhage in a cerebral hemisphere or the brainstem;
- Unilateral upper limb paresis with a motricity index between 9 and 99;
- Possibility to start cTBS treatment within 21 days after stroke onset;
- Signed informed consent.
- Upper limb paresis prior to stroke onset;
- Absolute contra-indication to TMS
- Magnetic sensitive objects implanted in the head or neck area (e.g. cochlear implants, implanted neurostimulator, pacemaker or defibrillator, metal splinters, metal fragments or metal clips);
- History of epilepsy;
- Other contra-indications that may potentially be harmful as determined by the treating rehabilitation physician;
- Severe impairments that can impede study participation as determined by the treating rehabilitation physician (i.e. extreme fatigue, severe communication deficits);
- Life expectancy shorter than one year.
The study team makes the final eligibility decision.
Where it's taking place
- 's-Hertogenbosch, Netherlands
- Amsterdam, Netherlands
- Beetsterzwaag, Netherlands
- Breda, Netherlands
- Doorn, Netherlands
- Eindhoven, Netherlands
- Groesbeek, Netherlands
- Hilversum, Netherlands
- Hoensbroek, Netherlands
- Leiden, Netherlands
- Nijmegen, Netherlands
- The Hague, Netherlands
- Tilburg, Netherlands
- Utrecht, Netherlands
- Wijk aan Zee, Netherlands
- Zwolle, Netherlands
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include 's-Hertogenbosch, Netherlands; Amsterdam, Netherlands; Beetsterzwaag, Netherlands; Breda, Netherlands; Doorn, Netherlands; Eindhoven, Netherlands and 10 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.